- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04989088
Neurofeedback Training for Dyslexia
July 24, 2021 updated by: Alice Cancer, Catholic University of the Sacred Heart
Neurofeedback Training to Restore Hemispheric Imbalance in Dyslexia
The study aims at testing a Neurofeedback (NF) training specifically designed for inducing a functional hemispheric imbalance of the tempo-parietal regions in individuals with dyslexia.
A randomized clinical trial aimed at comparing two experimental conditions is described: a) Left theta/beta NF training in combination with right beta/theta NF training and b) sham NF training.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alice Cancer, PhD
- Phone Number: 0272342284
- Email: alice.cancer@unicatt.it
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 35 years (ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of dyslexia or reading performance 2 SD below the norm
- Average intelligence
Exclusion Criteria:
- Psychiatric conditions
- Comorbidity with neurodevelopmental disorders
- Neurological disorders
- Epilepsy
- Enrollment in linguistic or literature university courses
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Left theta/beta and right beta/theta NF training
|
Left theta/beta NF training in combination with right beta/theta NF training in temporo-parietal regions, for 40 minutes (with a 20-minute break period)
|
PLACEBO_COMPARATOR: Sham NF training
|
Sham NF training using pre-recorded videos, for 40 minutes (with a 20-minute break period)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
EEG recording - ProComp5 Infiniti System
Time Frame: 1 hour
|
EEG power in theta/beta band recording in TP7 and TP8
|
1 hour
|
Phonological task (Spironelli & Angrilli, 2006) accuracy
Time Frame: 1 hour
|
Computerized rhyme decision task - n. of errors
|
1 hour
|
Phonological task (Spironelli & Angrilli, 2006) speed
Time Frame: 1 hour
|
Computerized rhyme decision task - response time (ms)
|
1 hour
|
Semantic task (Spironelli & Angrilli, 2006) speed
Time Frame: 1 hour
|
Computerized semantic decision task - response time (ms)
|
1 hour
|
Semantic task (Spironelli & Angrilli, 2006) accuracy
Time Frame: 1 hour
|
Computerized semantic decision task - n. of errors
|
1 hour
|
Text reading speed - LSC-SUA Battery (Cornoldi, Montesano & Valenti, 2020)
Time Frame: 1 hour
|
Text reading speed measured in syllables / seconds
|
1 hour
|
Text reading accuracy - LSC-SUA Battery (Cornoldi, Montesano & Valenti, 2020)
Time Frame: 1 hour
|
Text reading accuracy measured in n. of errors
|
1 hour
|
Word reading speed - LSC-SUA Battery (Cornoldi, Montesano & Valenti, 2020)
Time Frame: 1 hour
|
Word reading speed measured in syllables / seconds
|
1 hour
|
Word reading accuracy - LSC-SUA Battery (Cornoldi, Montesano & Valenti, 2020)
Time Frame: 1 hour
|
Word reading accuracy measured in n. of errors
|
1 hour
|
Psuedo-word reading speed - LSC-SUA Battery (Cornoldi, Montesano & Valenti, 2020)
Time Frame: 1 hour
|
Psuedo-word reading speed in syllables / seconds
|
1 hour
|
Psuedo-word reading accuracy - LSC-SUA Battery (Cornoldi, Montesano & Valenti, 2020)
Time Frame: 1 hour
|
Psuedo-word reading accuracy measured in n. of errors
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rapid automatized naming speed (RAN, De Luca, Di Filippo, Judica, Spinelli & Zoccolotti, 2005)
Time Frame: 1 hour
|
Rapid automatized naming (RAN) speed measured in seconds
|
1 hour
|
Rapid automatized naming accuracy (RAN, De Luca, Di Filippo, Judica, Spinelli & Zoccolotti, 2005)
Time Frame: 1 hour
|
Rapid automatized naming (RAN) accuracy measures in n. of errors
|
1 hour
|
Digit Span (Wechsler Adult Intelligence Scale - Fourth Edition, WAIS-IV)
Time Frame: 1 hour
|
Digit forward and digit backword task
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
October 1, 2021
Primary Completion (ANTICIPATED)
January 1, 2022
Study Completion (ANTICIPATED)
June 1, 2022
Study Registration Dates
First Submitted
July 15, 2021
First Submitted That Met QC Criteria
July 24, 2021
First Posted (ACTUAL)
August 4, 2021
Study Record Updates
Last Update Posted (ACTUAL)
August 4, 2021
Last Update Submitted That Met QC Criteria
July 24, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NF-DYSL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyslexia
-
Catholic University of the Sacred HeartFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione I.R...Enrolling by invitationDevelopmental DyslexiaItaly
-
University of ZurichUnknown
-
Bambino Gesù Hospital and Research InstituteRecruitingDevelopmental DyslexiaItaly
-
Bambino Gesù Hospital and Research InstituteEnrolling by invitationDevelopmental DyslexiaItaly
-
Scalab CNRS 9193UnknownDevelopmental DyslexiaFrance
-
Catholic University of the Sacred HeartUnknown
-
University Hospital, ToursCompleted
-
IRCCS Eugenio MedeaFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; University of MilanRecruiting
-
Georgia State UniversityMedical University of South Carolina; National Institutes of Health (NIH)CompletedDevelopmental Reading Disorder | Dyslexia, DevelopmentalUnited States
-
Università Vita-Salute San RaffaeleRecruiting
Clinical Trials on ProComp5 Infiniti System w/BioGraph Infiniti Software
-
IRCCS San Camillo, Venezia, ItalyCompletedDeglutition Disorders | Dysphagia, Late Effect of StrokeItaly
-
Kyungpook National University HospitalCompletedPhacoemulsificationKorea, Republic of
-
The Cleveland ClinicCompleted
-
Alcon ResearchCompleted
-
Innovative MedicalCompleted
-
Iladevi Cataract and IOL Research CenterCompleted
-
Abbott Medical OpticsCompletedCataractDominican Republic
-
Democritus University of ThraceCompleted